Ngapas, Rahma M.

HRN: 10-43-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/21/2022
05/27/2022
IVT
2.25
Q6
Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Wrong Dose

Overall appropriateness: No  Wrong Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: